A new IDH1/2 inhibitor for mutated IDH1/2 low-grade glioma

Brain tumors are rare but difficult to manage. Glioma is the most common type of tumor in the brain that begins in glial cells. IDH1/2 genes are important genes in both glioma classification and targeted therapy treatment. Adult diffuse gliomas of grade II and III are classified as low-grade gliomas based on the histology and molecular biomarkers by the 2016 World Health Organization (WHO) classification.

More >>